{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "R1441C",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "Arg",
            "alt": "Cys",
            "position": "1441"
          },
          "Description in input context": "R1441C mutation reduces interaction with Akt1."
        },
        {
          "HGVS": "G2019S",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "Gly",
            "alt": "Ser",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation reduces interaction with Akt1."
        },
        {
          "HGVS": "I2020T",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "Ile",
            "alt": "Thr",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation reduces interaction with Akt1."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0004937"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "LRRK2 and Akt1",
        "Description": "Kinase activity was measured using recombinant LRRK2 and Akt1."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "R1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "The R1441C mutation reduces LRRK2's ability to phosphorylate Akt1."
        },
        {
          "Variant": "G2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "The G2019S mutation reduces LRRK2's ability to phosphorylate Akt1."
        },
        {
          "Variant": "I2020T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "The I2020T mutation reduces LRRK2's ability to phosphorylate Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal kinase activity levels are defined as 100% phosphorylation of Akt1.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal kinase activity levels are defined as less than 50% phosphorylation of Akt1.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Pull-down assay",
      "Material used": {
        "Material Source": "Intact cells",
        "Material Name": "LRRK2 and Akt1 proteins",
        "Description": "Binding interaction was measured using pull-down assays with intact cells."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "R1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding interaction",
          "Result Description": "The R1441C mutation reduces the binding interaction between LRRK2 and Akt1."
        },
        {
          "Variant": "G2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding interaction",
          "Result Description": "The G2019S mutation reduces the binding interaction between LRRK2 and Akt1."
        },
        {
          "Variant": "I2020T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding interaction",
          "Result Description": "The I2020T mutation reduces the binding interaction between LRRK2 and Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal binding interaction is defined as detectable levels of LRRK2-Akt1 complex formation.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal binding interaction is defined as undetectable or significantly reduced levels of LRRK2-Akt1 complex formation.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}